American Financial Group (AFG) is scheduled to release its fourth-quarter earnings after the market closes on Tuesday, with analysts anticipating flat revenue growth. The report comes as the property & casualty insurance sector faces headwinds from policy uncertainty and market volatility.
As J&J Snack Foods prepares to release its quarterly results, investors are weighing stable analyst expectations against a backdrop of mixed performance in the shelf-stable food sector.
After a November dip, Texas's upstream oil and gas sector added 2,000 jobs in December, contributing to the state's record-breaking employment figures and underscoring the industry's pivotal role in the Texan economy and tax base.
While the healthcare sector has surged 17.4% in six months, outpacing the S&P 500, regulatory headwinds and valuation concerns demand a selective approach. We examine one stock with a durable edge and two facing significant challenges.
The financial services sector, a traditional engine of economic growth, is underperforming the S&P 500 amid economic uncertainty. We examine three specific stocks—Invesco, Enova International, and Sixth Street Specialty Lending—that investors may want to approach with heightened caution.
Two financial sector giants, S&P Global and Goldman Sachs, have announced increased quarterly payouts, signaling confidence in their financial health and future prospects amid a dynamic market environment.
The U.S. rig count saw a marginal increase this week, yet remains significantly below last year's levels as crude production dips and completions activity sends conflicting signals.
Crude oil and gasoline prices advanced on Friday, supported by persistent geopolitical risks in the Middle East and ongoing supply constraints, though gains were tempered by a stronger dollar and diplomatic signals.
Exxon Mobil and Chevron reported declines in full-year earnings as a sustained oil surplus pressured prices, though both companies highlighted strategic shifts toward LNG, chemicals, and power projects to fuel future growth.
Bank of America has raised its price target for clinical-stage biopharma firm Xencor (XNCR), highlighting a cautiously improving landscape for the sector driven by data catalysts, M&A, and capital access.
Arthur J. Gallagher & Co. reported robust revenue growth exceeding 30% for the fourth quarter of 2025, driven by a healthy mergers and acquisitions pipeline and resilient performance in key sectors. Leadership expressed confidence in navigating a softening property insurance market while maintaining stable casualty pricing and talent retention.
Global markets opened the week under pressure, with Asian shares and U.S. futures declining amid renewed concerns over an AI sector bubble and falling commodity prices. South Korea's Kospi led losses with a sharp 4.6% drop.
Despite political pressure and vast reserves, U.S. oil majors ExxonMobil and Chevron are taking a cautious stance on new spending in Venezuela, demanding legal stability and fiscal reforms before committing fresh capital, even as they signal long-term interest.
While the sales and marketing software segment broadly exceeded revenue expectations in Q3, investor sentiment has turned sour, with most stocks falling post-earnings. We analyze the divergent performances of Upland Software, Sprinklr, DoubleVerify, PubMatic, and Sprout Social.
ExxonMobil and Chevron signal that significant investment in Venezuela's vast oil reserves hinges on clearer legal and fiscal stability, despite recent political changes and White House pressure.
In a landmark shift, Venezuela's parliament has passed sweeping reforms to its hydrocarbons law, aiming to lure private capital into its crippled oil industry. The move, backed by a new U.S. license, signals a potential turning point for the nation's economy.
Despite a challenging price environment, Murphy Oil (MUR) reported strong operational execution for 2025 and laid out a capital plan focused on funding key international and offshore projects. While near-term production is set to dip, CEO Eric Hambly highlighted a transformative discovery in Vietnam and strategic portfolio expansion as pillars for future growth.
The medtech giant inaugurates a Centre of Excellence in Swords, aiming to accelerate development of its Atellica diagnostic systems and bolster Ireland's life sciences sector amid strategic corporate shifts.
While Bed Bath & Beyond shares fell 13%, insiders who bought in the last year remain in profit, highlighting a potential disconnect between internal confidence and market sentiment.
Insurance brokerage giant Brown & Brown sees a key price target cut to $81 following its fourth-quarter earnings, which revealed robust fee growth but concerns over slowing organic revenue expansion.
